AMNIOGEL
Extracellular matrix derived products from human placenta to engineer bone microtissues for in vitro disease models.
| Grant period | 2020-09-01 - 2022-10-31 |
| Funding body | European Union |
| Call number | ERC-2020-PoC |
| Grant number | 957585 |
| Identifier | G:(EU-Grant)957585 |